The 5-year local control ( LC ) , regional control , distant metastasis-free survival ( DMFS ) , disease free survival , disease specific survival , and overall survival ( OS ) rates were 89.8 % , 95.2 % , 74.1 % , 69.6 % , 83.2 % , and 77.1 % .